TY  - JOUR
AU  - Cuende, Natividad
AU  - Ciccocioppo, Rachele
AU  - Forte, Miguel
AU  - Galipeau, Jacques
AU  - Ikonomou, Laertis
AU  - Levine, Bruce L
AU  - Srivastava, Alok
AU  - Zettler, Patricia J
PY  - 2022
DO  - 10.1016/j.jcyt.2022.03.007
UR  - http://hdl.handle.net/10668/22299
T2  - Cytotherapy
AB  - Hospital exemption (HE) is a regulated pathway that allows the use of advanced therapy medicinal products (ATMPs) within the European Union (EU) under restrictive conditions overseen by national medicine agencies. In some EU countries, HE is granted...
LA  - en
KW  - accessibility
KW  - advanced therapy medicinal products
KW  - ethics
KW  - hospital exemption
KW  - risk–benefit
KW  - transparency
KW  - Cell- and Tissue-Based Therapy
KW  - Commerce
KW  - European Union
KW  - Hospitals
KW  - Humans
KW  - Therapies, Investigational
TI  - Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products.
TY  - research article
VL  - 24
ER  -